Citadel Advisors’s Sharps Compliance Corp SMED Stock Holding History

Citadel Advisors’s Portfolio SMED Stock Details SMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-12,000	Closed	-$86K	–	15136
2021 Q4	$86K	Sell	12,000 -3,200	-21%	-$24.6K	﹤0.01%	12869
2021 Q3	$126K	Buy	15,200 +100	+0.7%	+$930	﹤0.01%	12591
2021 Q2	$156K	Sell	15,100 -1,200	-7%	-$16.7K	﹤0.01%	12467
2021 Q1	$234K	Buy	+16,300	New	+$210K	﹤0.01%	11403
2020 Q4	–	Sell	-14,400	Closed	-$90K	–	11753
2020 Q3	$90K	Buy	+14,400	New	+$105K	﹤0.01%	9339
2015 Q4	–	Sell	-1,700	Closed	-$15K	–	9376
2015 Q3	$15K	Buy	+1,700	New	+$12.3K	﹤0.01%	8336

Citadel Advisors's SMED Position: Q3 2022 in Review

Citadel Advisors sold out of Sharps Compliance Corp (SMED) in Q3 2022, closing a stake of 62,818 shares — an estimated $184K sold.

Citadel Advisors first reported a position in SMED in Q1 2014 and held it in 11 quarters. The position peaked at $1.31M in Q2 2021. 0 funds tracked by Wall St. Rank hold SMED as of Q3 2022.

Citadel Advisors reported no remaining Sharps Compliance Corp position as of Q3 2022 after selling out during the quarter.
Citadel Advisors sold 62,818 Sharps Compliance Corp shares in Q3 2022, an estimated $184K.
Citadel Advisors first reported a position in Sharps Compliance Corp in Q1 2014 and held it in 11 quarters.
Citadel Advisors's Sharps Compliance Corp position peaked at $1.31M in Q2 2021.
0 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q3 2022.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.